Kathleen Ford
Chief Operating Officer chez KURA ONCOLOGY, INC.
Fortune : 460 771 $ au 31/03/2024
Profil
Kathleen Ford is currently the Chief Operating Officer at Kura Oncology, Inc. She previously worked as the Director of Clinical Operations at Alkermes, Inc. and Alkermes Plc from 1993 to 2002.
From 2012 to 2017, she served as the Senior VP and Head of Global Clinical Operations at Merck Serono GmbH.
Additionally, she held the position of Vice President of Clinical Operations at Millennium Pharmaceuticals, Inc. from 2002 to 2009.
Ms. Ford obtained her undergraduate degree from Fitchburg State College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KURA ONCOLOGY, INC.
0,03% | 29/01/2024 | 21 602 ( 0,03% ) | 460 771 $ | 31/03/2024 |
Postes actifs de Kathleen Ford
| Sociétés | Poste | Début |
|---|---|---|
| KURA ONCOLOGY, INC. | Chief Operating Officer | 09/08/2019 |
Anciens postes connus de Kathleen Ford
| Sociétés | Poste | Fin |
|---|---|---|
Merck Serono GmbH
 Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2009 |
| ALKERMES PLC | Chief Tech/Sci/R&D Officer | 01/01/2002 |
Formation de Kathleen Ford
| Fitchburg State College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KURA ONCOLOGY, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Health Technology |
